New nasal steroid spray otc

RHINOCORT® is a licensed trademark of AstraZeneca AB. © J&JCI 2016. All rights reserved. This site is published by Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division, which is solely responsible for its contents. This website is intended for visitors from the United States. The third-party trademarks used herein are registered trademarks of their respective owners. Questions and comments? Call 1-800-343-7805, Monday to Friday, 9 am – 7 pm ET, except holidays. If you reside outside of the United States, you can call us. Click here for a list of telephone numbers by country. This site may contain links to websites to which our privacy policy does not apply. We encourage you to read the privacy policy of every website you visit.

QNASL Nasal Aerosol is a pressurized, nonaqueous solution in a metered-dose aerosol device intended ONLY for intranasal use. It contains a solution of beclomethasone dipropionate in propellant HFA-134a (1,1,1,2-tetrafluoroethane) and dehydrated ethanol. QNASL 40 mcg Nasal Aerosol delivers 40 mcg of beclomethasone dipropionate from the nasal actuator and 50 mcg from the valve. QNASL 80 mcg Nasal Aerosol delivers 80 mcg of beclomethasone dipropionate from the nasal actuator and 100 mcg from the valve. Each strength delivers 59 mg of solution from the valve with each actuation. Each canister of QNASL 40 mcg or 80 mcg Nasal Aerosol, contains  g of drug and excipients and each provides 120 actuations after priming. Additionally, QNASL 40 mcg Nasal Aerosol contains g of drug and excipients and provides 60 actuations after priming.

New nasal steroid spray otc

new nasal steroid spray otc

Media:

new nasal steroid spray otcnew nasal steroid spray otcnew nasal steroid spray otcnew nasal steroid spray otcnew nasal steroid spray otc

http://buy-steroids.org